An exploratory test for an excess of significant findingsBumps and bridges on the road to responsible sharing of clinical trial dataInformed consent in clinical research: Consensus recommendations for reform identified by an expert interview panelMeasures of follow-up in time-to-event studies: Why provide them and what should they be?A modified toxicity probability interval method for dose-finding trials.Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis TrialDesign of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis TrialKey cost drivers of pharmaceutical clinical trials in the United StatesAssessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialEvaluating interventions for Ebola: The need for randomized trialsThe national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directionsThe automation of clinical trial serious adverse event reporting workflowDesigning and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).Providing the results of research to participants: a mixed-method study of the benefits and challenges of a consultative approachSummarizing historical information on controls in clinical trialsA response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseBalancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe.An introduction to causal modeling in clinical trials.Long-term drug prevention trials.Strategies for successful rapid trials of influenza vaccine.Performance of two-stage continual reassessment method relative to an optimal benchmarkUsefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trial.Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsDose-finding design for multi-drug combinations.Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III designRedesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.HLA genotyping in the international Type 1 Diabetes Genetics ConsortiumStatistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trials.Bayesian design of single-arm phase II clinical trials with continuous monitoring.Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study.Factors influencing enrollment of African Americans in the Look AHEAD trial.How good does the science have to be in proposals submitted to Institutional Review Boards? An interview study of Institutional Review Board personnel.Meta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questions.Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.Adaptive adjustment of the randomization ratio using historical control data.Data collection in cancer clinical trials: Too much of a good thing?Clinician-trialist rounds: 19. Faux pas or fraud? Identifying centers that have fabricated their data in your multi-center trial.Inference from blinded data in randomized clinical trials.Central and statistical data monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.
P1433
Q24273224-BD7146F3-2874-4AFB-A43F-3C195446494CQ26284593-96391C88-A7BE-4ADA-9502-D4EDBA7FBD65Q26801171-483D93D9-30CF-41CF-BD5E-7249BC1962B8Q27022887-34802F5B-DF8E-4E18-A49F-8B8E346FF057Q27323581-8A90449E-1E9F-414E-9D2D-204A510101E2Q28193653-41F283A6-44CF-410F-9D3F-BEFB3A1E583DQ28193662-C4E3B1F5-66ED-4A47-91CA-3D6FC1EA22DDQ28273573-D665A4E9-5CC9-4A6F-9CB5-CB12CF9AA535Q28286011-B1A26583-BC56-4E23-A179-FAF8789CD9B4Q28388002-2C3A714A-CE37-4DA5-9DB8-EB67869C4266Q28658616-740C5DF8-2CBA-4828-A18C-F4E620E6DDE9Q28740446-0743A12B-15B6-44E2-9BF3-5D87A9237585Q28749882-B569B2F1-44B4-4177-BC41-E0EA2EC0419FQ28816152-7D3BBF55-967F-4E72-9378-DBE70349D488Q29397593-A2FD1293-C5CF-4298-8204-7A57BD9D259FQ30196960-5D4D4B1A-A015-4CC0-8466-EB25986EC103Q30228872-00BFC0A9-276F-4EB4-8780-6BB5948F06F2Q30360089-8DD63727-4E20-4229-A4D5-AB7ADFC263BCQ30368543-899C9EA2-2D11-4E53-AFCB-6D59EA447572Q30406834-8CF75A06-1312-43CC-8BF9-0C6D707EE63BQ30407451-0317C7A8-F9B6-4E60-9C8A-656173878522Q30410657-5426A3DE-10C1-46F6-A38C-5436A41EAC80Q30413922-740DD724-FD1D-437E-8073-314D0DCB4412Q30424392-DC457B23-5BFF-44F6-BFF4-CB4A63483AA6Q30424507-71BE289F-5783-42EB-B320-9FC7254193ADQ30430118-50D51094-5859-4BCC-85C5-E3D3B1A5AED1Q30432603-1B5B99FD-3169-4073-8BD9-CBE023D22848Q30435115-64CE0FB9-EBE1-4BFE-86D9-323F2D6A1437Q30454523-FFD699EC-13ED-4A8D-A5FB-01F2A43FADACQ30484175-4DF2F706-F66E-491A-A29A-5AAB8F07CE12Q30548231-7A5A5435-F85E-4170-8AA3-D6682B67D3CEQ30558143-C7CE4B1D-1A1D-4B49-A133-800FCA624E05Q30571254-B337ADE5-B18A-40C8-93C9-FA89F7BDCEE3Q30578166-E289D2C8-FA79-44D1-A52E-AC1975384EF0Q30586122-504EECB1-0DCC-470D-B536-E1B88AD8D909Q30629562-FEED81B8-609C-407B-A0C4-42AD0660FEA1Q30650486-9A78AA32-06A5-4ECF-9EAF-E45F8B6AB156Q30671530-4B088432-EC8F-447E-8189-F4A578CFBF08Q30678364-3015E5B9-64F0-4960-B958-D68C7B53C5E7Q30717253-592C8D43-DEE1-464E-BCBA-CA82EAEBC5E2
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van SAGE Publications
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Clinical Trials
@ast
Clinical Trials
@da
Clinical Trials
@en
Clinical Trials
@es
Clinical Trials
@fi
Clinical Trials
@fr
Clinical Trials
@it
Clinical Trials
@nb
Clinical Trials
@nl
Clinical Trials
@nn
type
label
Clinical Trials
@ast
Clinical Trials
@da
Clinical Trials
@en
Clinical Trials
@es
Clinical Trials
@fi
Clinical Trials
@fr
Clinical Trials
@it
Clinical Trials
@nb
Clinical Trials
@nl
Clinical Trials
@nn
prefLabel
Clinical Trials
@ast
Clinical Trials
@da
Clinical Trials
@en
Clinical Trials
@es
Clinical Trials
@fi
Clinical Trials
@fr
Clinical Trials
@it
Clinical Trials
@nb
Clinical Trials
@nl
Clinical Trials
@nn
P243
P3181
P1055
P1058
P1144
2004256012
P1156
P1160
clin. trials.
P123
P1250
P1277
P1476
Clinical Trials
@en
P236
P243
P3181
P407
P571
2004-01-01T00:00:00Z